What tests would be indicated in a patient experiencing recurrent hypoglycemia, with normal cortisol levels, elevated Thyroid-Stimulating Hormone (TSH) levels, and recently initiated on levothyroxine (thyroxine), to investigate potential adrenal insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For a patient with recurrent hypoglycemia, normal cortisol, and high TSH who has started levothyroxine, I would not start cortisol supplementation without evidence of adrenal insufficiency. Instead, I would order additional tests including insulin and C-peptide levels to evaluate for insulinoma or inappropriate insulin secretion, sulfonylurea screen to rule out surreptitious use, IGF-1 and growth hormone to assess for growth hormone deficiency, and comprehensive metabolic panel to evaluate liver function. I would also check for antibodies against insulin receptors and consider a 72-hour fasting test to provoke hypoglycemia under controlled conditions. Hypothyroidism can cause hypoglycemia, so optimizing thyroid replacement with levothyroxine may resolve the issue. Starting cortisol without confirmed adrenal insufficiency could cause harmful side effects including immunosuppression, osteoporosis, and metabolic derangements. The patient should be advised to monitor blood glucose regularly, carry fast-acting carbohydrates, and follow up closely to assess response to thyroid replacement therapy.

Some key points to consider in this patient's evaluation include:

  • The potential for hypothyroidism to cause hypoglycemia, as noted in the patient's high TSH levels 1
  • The importance of confirming adrenal insufficiency before initiating cortisol supplementation, as supported by the study on defective cortisol secretion in response to spontaneous hypoglycemia in neonates with hyperinsulinemic hypoglycemia 2
  • The utility of the overnight single-dose metyrapone test as a simple and reliable index of the hypothalamic-pituitary-adrenal axis, as demonstrated in the study on the performance of the overnight metyrapone test 3
  • The need to consider other potential causes of hypoglycemia, such as insulinoma or inappropriate insulin secretion, and to evaluate for these conditions through additional testing 4, 5

Overall, a comprehensive evaluation of this patient's condition, including consideration of the potential causes of hypoglycemia and the importance of confirming adrenal insufficiency before initiating treatment, is necessary to provide appropriate care and minimize the risk of harmful side effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.